Huntsworth Acquires Nucleus Global

November 12, 2020

Huntsworth, an international healthcare and communications group, has announced an agreement to acquire Nucleus Global, one of the largest medical specialist communications group in the world. With the addition of Nucleus Global, Huntsworth will provide pharmaceutical and biotechnology companies with the most complete suite of strategic counsel, medical affairs, market access, stakeholder engagement and marketing services across all therapeutic areas and across the entire drug development and commercialization lifecycle of molecule to medicine.

“The addition of Nucleus Global to Huntsworth creates one of the largest high science teams in the world to meet the increasingly complex needs of next generation prescription drug development,” said Paul Taaffe, CEO of Huntsworth. “Together, Nucleus Global, and Huntsworth are one of the most powerful combinations in healthcare communications.” Read more here.

Share This Story!